Who Benefits?

Who Benefits? Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Who Benefits? Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy. / Holtug, Nils; Sandøe, Peter.

In: Journal of Applied Philosophy, Vol. 13, No. 2, 1996, p. 157-166.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Holtug, N & Sandøe, P 1996, 'Who Benefits? Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy', Journal of Applied Philosophy, vol. 13, no. 2, pp. 157-166.

APA

Holtug, N., & Sandøe, P. (1996). Who Benefits? Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy. Journal of Applied Philosophy, 13(2), 157-166.

Vancouver

Holtug N, Sandøe P. Who Benefits? Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy. Journal of Applied Philosophy. 1996;13(2):157-166.

Author

Holtug, Nils ; Sandøe, Peter. / Who Benefits? Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy. In: Journal of Applied Philosophy. 1996 ; Vol. 13, No. 2. pp. 157-166.

Bibtex

@article{c5dd5e20935311dcbee902004c4f4f50,

title = "Who Benefits?: Why Personal Identity Does Not Matter in a Moral Evaluation of Germ-line Gene Therapy",

author = "Nils Holtug and Peter Sand{\o}e",

year = "1996",

language = "English",

volume = "13",

pages = "157--166",

journal = "Journal of Applied Philosophy",

issn = "0264-3758",

publisher = "Wiley-Blackwell",

number = "2",